CJC-1295 (no DAC)

A stabilised GHRH(1-29) analogue without the drug-affinity complex.

CJC-1295 (no DAC) · 5 mg · Lyophilised vial

peptide · also known as Mod GRF 1-29

CJC-1295 (no DAC)

A stabilised GHRH(1-29) analogue without the drug-affinity complex.

€ 30.00per vial, EUR

In stock

Presentation2 options

5 mg · Lyophilised vial€ 30.00 10 mg · Lyophilised vial€ 50.00

Lyophilised powder in a sealed glass vial

Storage: -20 °C for long-term storage; 2 to 8 °C for under three months; away from light

Tracked shipping EUR 9.95 per order. Benelux 1 to 2 business days, Germany and France 2 to 3, rest of Europe 3 to 5. Details

Batch certificate: not yet published online. Request one for this presentation.

Research use only. Not for human or veterinary use.

What it is

CJC-1295 without DAC (also called Modified GRF 1-29) is a 29-amino-acid analogue of growth-hormone-releasing hormone with four amino-acid substitutions that slow enzymatic breakdown. Without the DAC group it has a short half-life and a pulsatile action profile in research models.

Where it has been studied

Literature search: PubMed, "modified GRF 1-29 CJC-1295". The areas listed describe published research, not outcomes.

Pituitary growth-hormone release in cell and animal models
GHRH receptor pharmacology
Comparison studies with DAC-conjugated analogues

Specifications

Compound	CJC-1295 (no DAC) (Mod GRF 1-29)
Type	Peptide
Selected presentation	5 mg · Lyophilised vial
Form	Lyophilised powder in a sealed glass vial
Fill volume and concentration	Not applicable (lyophilised)
Label	CELVIVE wordmark, compound name, amount, "Purity: >99%", "For research use only"
Storage	-20 °C for long-term storage; 2 to 8 °C for under three months; away from light
Certificate of analysis	Not yet published online. Request for a batch
Research areas	Growth hormone axis
All presentations	5 mg lyophilised vial · € 30.00 10 mg lyophilised vial · € 50.00

Handling

Lyophilised peptides tolerate room temperature for several weeks in transit. Move to cold storage on receipt.
Reconstituted vials are typically used within three to four weeks at 2 to 8 °C; stability varies by compound.
Opened or unsealed vials cannot be returned. Transit damage must be documented within 24 hours.

Storage and stability FAQ